Stay updated on Durvalumab Combinations in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Combinations in NSCLC Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.4 was added to the Record History, replacing v3.5.3. This marks a new version of the study record.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s interface/version footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a site software release rather than a change to the underlying clinical trial record history.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the study record history.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 in the history list.SummaryDifference0.1%

- Check97 days agoChange DetectedAdded Revision: v3.4.2 to the history and removed the earlier funding-lapse notice (v3.4.1).SummaryDifference0.5%

Stay in the know with updates to Durvalumab Combinations in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.